《新股表现》飞鹤(06186.HK)暗盘开报7.8元 高上市价4%
根据辉立交易平台显示,明天挂牌的中国飞鹤(06186.HK)暗盘高开4%报7.8元,最多升6.7%高见8元遇阻,掉头低见7.29元,现造7.4元,较上市价7.5元,低1.3%,成交565万股。
飞鹤是内地最大兼广为人所知的中国品牌婴幼儿配方奶粉生产商。是次来港上市共发售8.9334亿股,其中10%公开发售获逾12倍超购,认购一手中签率65%;股份以招股范围(7.5-10元)下限定价,料集资净额65.64亿元,主要用作还债、潜在并购、建设加拿大金斯顿厂房,以及用作海外婴幼儿配方奶粉和营养补充品研发活动等。上市联席保荐人分别为摩通、招商证券及建银国际。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.